PROTO LABS INC (PRLB)

US7437131094 - Common Stock

33.86  -4.14 (-10.89%)

After market: 33.86 0 (0%)

Fundamental Rating

5

PRLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 131 industry peers in the Machinery industry. PRLB is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. While showing a medium growth rate, PRLB is valued expensive at the moment.



4

1. Profitability

1.1 Basic Checks

In the past year PRLB was profitable.
In the past year PRLB had a positive cash flow from operations.
Of the past 5 years PRLB 4 years were profitable.
In the past 5 years PRLB always reported a positive cash flow from operatings.

1.2 Ratios

PRLB's Return On Assets of 3.27% is in line compared to the rest of the industry. PRLB outperforms 48.44% of its industry peers.
PRLB has a Return On Equity of 3.62%. This is comparable to the rest of the industry: PRLB outperforms 42.97% of its industry peers.
With a Return On Invested Capital value of 2.76%, PRLB is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
PRLB had an Average Return On Invested Capital over the past 3 years of 2.51%. This is significantly below the industry average of 11.02%.
The 3 year average ROIC (2.51%) for PRLB is below the current ROIC(2.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.27%
ROE 3.62%
ROIC 2.76%
ROA(3y)-2.36%
ROA(5y)1.84%
ROE(3y)-2.78%
ROE(5y)2.09%
ROIC(3y)2.51%
ROIC(5y)4.14%

1.3 Margins

PRLB has a Profit Margin of 4.87%. This is comparable to the rest of the industry: PRLB outperforms 52.34% of its industry peers.
PRLB's Profit Margin has declined in the last couple of years.
The Operating Margin of PRLB (6.21%) is comparable to the rest of the industry.
PRLB's Operating Margin has declined in the last couple of years.
The Gross Margin of PRLB (44.99%) is better than 86.72% of its industry peers.
PRLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.21%
PM (TTM) 4.87%
GM 44.99%
OM growth 3Y-25.76%
OM growth 5Y-22.35%
PM growth 3Y-33.68%
PM growth 5Y-27.61%
GM growth 3Y-4.22%
GM growth 5Y-3.83%

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRLB is destroying value.
The number of shares outstanding for PRLB has been reduced compared to 1 year ago.
Compared to 5 years ago, PRLB has less shares outstanding
Compared to 1 year ago, PRLB has an improved debt to assets ratio.

2.2 Solvency

PRLB has an Altman-Z score of 9.38. This indicates that PRLB is financially healthy and has little risk of bankruptcy at the moment.
PRLB has a better Altman-Z score (9.38) than 92.97% of its industry peers.
PRLB has a debt to FCF ratio of 0.02. This is a very positive value and a sign of high solvency as it would only need 0.02 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.02, PRLB belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that PRLB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, PRLB belongs to the top of the industry, outperforming 82.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Altman-Z 9.38
ROIC/WACC0.3
WACC9.11%

2.3 Liquidity

PRLB has a Current Ratio of 4.08. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
PRLB has a better Current ratio (4.08) than 85.94% of its industry peers.
A Quick Ratio of 3.83 indicates that PRLB has no problem at all paying its short term obligations.
The Quick ratio of PRLB (3.83) is better than 89.84% of its industry peers.
Industry RankSector Rank
Current Ratio 4.08
Quick Ratio 3.83

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.14% over the past year.
The earnings per share for PRLB have been decreasing by -12.05% on average. This is quite bad
PRLB shows a small growth in Revenue. In the last year, the Revenue has grown by 3.17%.
Measured over the past years, PRLB shows a small growth in Revenue. The Revenue has been growing by 2.49% on average per year.
EPS 1Y (TTM)22.14%
EPS 3Y-12.27%
EPS 5Y-12.05%
EPS Q2Q%-7.84%
Revenue 1Y (TTM)3.17%
Revenue growth 3Y5.07%
Revenue growth 5Y2.49%
Sales Q2Q%-3.89%

3.2 Future

PRLB is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.82% yearly.
PRLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.13% yearly.
EPS Next Y-10.93%
EPS Next 2Y-2.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.33%
Revenue Next 2Y1.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.80, the valuation of PRLB can be described as rather expensive.
PRLB's Price/Earnings is on the same level as the industry average.
PRLB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 30.20.
With a Price/Forward Earnings ratio of 22.41, PRLB is valued on the expensive side.
Based on the Price/Forward Earnings ratio, PRLB is valued a bit more expensive than the industry average as 60.94% of the companies are valued more cheaply.
PRLB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.28.
Industry RankSector Rank
PE 19.8
Fwd PE 22.41

4.2 Price Multiples

62.50% of the companies in the same industry are more expensive than PRLB, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, PRLB is valued a bit cheaper than the industry average as 73.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.36
EV/EBITDA 12.09

4.3 Compensation for Growth

PRLB's earnings are expected to decrease with -2.82% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.82%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PRLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (11/4/2024, 8:04:00 PM)

After market: 33.86 0 (0%)

33.86

-4.14 (-10.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap851.58M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 19.8
Fwd PE 22.41
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 3.62%
ROCE
ROIC
ROICexc
ROICexgc
OM 6.21%
PM (TTM) 4.87%
GM 44.99%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.08
Quick Ratio 3.83
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)22.14%
EPS 3Y-12.27%
EPS 5Y
EPS Q2Q%
EPS Next Y-10.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.17%
Revenue growth 3Y5.07%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y